Created in 2002 and having a nominal capital of 185.253.000,00 million DA, AAHP laboratory (Algerian Animal Health Product) is established in the great animal production zones. It manufactures conditions and markets medicinal products for veterinary use of liquid, solid and injectable forms. The industrial site located 266 industrial zone LE PALMA Ex: La Moricière 25000 Constantine, on a ground of 2237 m², has a production surface of 1539 m², and a surface of 1044 m² intended for the administrative offices. Our production units are distributed on two levels. The first level is intended for the manufacture of products of various forms and pharmaceutical classes. One manufactures drinkable solutions and suspensions there, as well as soluble powders. The second level concerns the manufacture of the injectable sterile solutions and of the intra mammary products. The products manufactured belong to various classes of antibiotics, sulphamides, pesticides and vitamins. To ensure the quality control of our products we have an internal laboratory for physicochemical and microbiological analysis, highly equipped: (2 HPLC, a UV spectrophotometer, a potentiométrique titrator Karl Fisher, a refract meter, a viscometer, three (3) drying ovens, an autoclave, two (2) climatic chambers for the studies of stability, an ultra sound bath, a Bain-marie and many other apparatuses because the list is non exhaustive. All the products manufactured are subjected to several controls before their release: a control in process, a control for the products in the course of conditioning and a control of the end products. In a permanent preoccupation of competitiveness, improvement and a technological survey, the company continuously provides its production units and its laboratory with new equipment and apparatuses, in order to answer the needs and expectations of the national and international customers. Our injectable products manufacturing site was validated by the European agency of the medicine and was certified GMP Good Manufacturing Practices. A biological products manufacturing site (vaccines) is under development to be operational before the end of the first quarter of the current year (2010). Our range is today of 46 products manufactured in the observance of the regulation and the standards in force and will be diversified and extended to 52 products for the year 2010. We hold today 15% of market shares at the national level and invested the international market. Our products are exported towards many countries in particular Libya, Morocco, Jordan, Egypt, Syria, Saudi Arabia, Sudan, Niger. We were awarded the prize of the best Algerian exporter of the year 2006, except hydrocarbons. AAHP was one of the first Algerian companies to adhere voluntarily to the program MEDA Euro Development PME (for the upgrading of the companies). We profited from an appreciable accompaniment which enabled us to as well know an evolution on several level